MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC - Medizinonline

… Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitreten Already a member? Log in here...

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Birke Dikken

Publikation

InFo ONKOLOGIE & HÄMATOLOGIE

Related Topics

Previous Article

Pathophysiological mechanisms and therapeutic perspectives

Metabolic syndrome in patients with schizophrenia

Pain and autism

Hurdles to pain treatment for autistic patients

You May Also Like

7 min

Steatotic liver disease

GLP-1RA in MASH – what’s new?

6 min

Chronic pruritus: “Tour d'horizon”

Focus on new anti-inflammatory therapeutic approaches

5 min

Multiple sclerosis

Unexpected side effects when switching from natalizumab to a biosimilar

3 min

Immunotherapy

Subcutaneously or intravenously?

- Congress Reports
- Oncology
- Pneumology
- RX
- Studies

4 min

Work-related asthma

When the job leads to exacerbations

0 min

Inoperable NSCLC

Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy

- Congress Reports
- Oncology
- Pneumology
- RX
- Studies

3 min

De-escalation strategies

De-escalation strategies – less is more

16 min

Pain and autism

Hurdles to pain treatment for autistic patients

Input your search keywords and press Enter.